Healthcare provider profile · identity verified

Mark Louis Skory, D.O.

Family Practice · AUBURN, MI · NPI 1417038449

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	474	124
Levothyroxine Sodium	Levothyroxine Sodium	391	84
Lisinopril	Lisinopril	382	96
Amlodipine Besylate	Amlodipine Besylate	202	53
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	192	27
Pantoprazole Sodium	Pantoprazole Sodium	189	53
Omeprazole	Omeprazole	185	47
Tamsulosin Hcl	Tamsulosin Hcl	181	42
Gabapentin	Gabapentin	173	39
Metformin Hcl Er	Metformin Hcl	160	37
Metoprolol Succinate	Metoprolol Succinate	150	37
Losartan Potassium	Losartan Potassium	145	32
Glimepiride	Glimepiride	139	39
Rosuvastatin Calcium	Rosuvastatin Calcium	119	31
Pravastatin Sodium	Pravastatin Sodium	114	28
Simvastatin	Simvastatin	113	27
Hydrochlorothiazide	Hydrochlorothiazide	105	27
Metformin Hcl	Metformin Hcl	105	27
Buspirone Hcl	Buspirone Hcl	103	23
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	99	20
Allopurinol	Allopurinol	90	19
Meloxicam	Meloxicam	90	26
Metoprolol Tartrate	Metoprolol Tartrate	87	21
Cephalexin	Cephalexin	79	61
Eliquis	Apixaban	78	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	78	18
Atenolol	Atenolol	77	20
Clopidogrel	Clopidogrel Bisulfate	75	20
Montelukast Sodium	Montelukast Sodium	74	19
Sertraline Hcl	Sertraline Hcl	70	15
Albuterol Sulfate Hfa	Albuterol Sulfate	69	24
Celecoxib	Celecoxib	69	18
Escitalopram Oxalate	Escitalopram Oxalate	68	19
Furosemide	Furosemide	68	21
Trulicity	Dulaglutide	68	13
Alendronate Sodium	Alendronate Sodium	64	suppressed
Tizanidine Hcl	Tizanidine Hcl	60	29
Potassium Chloride	Potassium Chloride	59	15
Famotidine	Famotidine	58	15
Ezetimibe	Ezetimibe	56	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	56	14
Ozempic	Semaglutide	56	suppressed
Carvedilol	Carvedilol	54	14
Trazodone Hcl	Trazodone Hcl	52	15
Farxiga	Dapagliflozin Propanediol	50	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	49	suppressed
Duloxetine Hcl	Duloxetine Hcl	49	16
Venlafaxine Hcl Er	Venlafaxine Hcl	49	12
Zolpidem Tartrate	Zolpidem Tartrate	48	suppressed
Pregabalin	Pregabalin	46	suppressed
Finasteride	Finasteride	45	suppressed
Xarelto	Rivaroxaban	45	suppressed
Alprazolam	Alprazolam	44	11
Citalopram Hbr	Citalopram Hydrobromide	40	suppressed
Donepezil Hcl	Donepezil Hcl	40	suppressed
Meclizine Hcl	Meclizine Hcl	38	11
Mounjaro	Tirzepatide	37	suppressed
Ibuprofen	Ibuprofen	36	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	suppressed
Azithromycin	Azithromycin	35	28
Fluoxetine Hcl	Fluoxetine Hcl	35	suppressed
Terazosin Hcl	Terazosin Hcl	35	suppressed
Tramadol Hcl	Tramadol Hcl	35	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	35	suppressed
Prednisone	Prednisone	34	27
Quetiapine Fumarate	Quetiapine Fumarate	34	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	suppressed
Fluticasone Propionate	Fluticasone Propionate	33	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	33	suppressed
Methylprednisolone	Methylprednisolone	32	25
Rybelsus	Semaglutide	32	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	31	suppressed
Ropinirole Hcl	Ropinirole Hcl	31	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	15
Betamethasone Valerate	Betamethasone Valerate	28	11
Testosterone Cypionate	Testosterone Cypionate	27	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	26	suppressed
Lorazepam	Lorazepam	26	suppressed
Propranolol Hcl	Propranolol Hcl	26	suppressed
Januvia	Sitagliptin Phosphate	25	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	25	suppressed
Clonazepam	Clonazepam	24	suppressed
Linzess	Linaclotide	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Propranolol Hcl Er	Propranolol Hcl	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Amoxicillin	Amoxicillin	22	18
Bisoprolol Fumarate	Bisoprolol Fumarate	22	suppressed
Vilazodone Hcl	Vilazodone Hcl	22	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Jardiance	Empagliflozin	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Methotrexate	Methotrexate Sodium	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Humalog Kwikpen U-100	Insulin Lispro	19	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	19	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Amiodarone Hcl	Amiodarone Hcl	17	suppressed
Colestipol Hcl	Colestipol Hcl	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Colchicine	Colchicine	16	suppressed
Raloxifene Hcl	Raloxifene Hcl	16	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Sf 5000 Plus	Fluoride (Sodium)	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Calcitriol	Calcitriol	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	13
Gemfibrozil	Gemfibrozil	14	suppressed
Nabumetone	Nabumetone	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Topiramate	Topiramate	14	suppressed
Chlorzoxazone	Chlorzoxazone	13	suppressed
Effer-K	Potassium Bicarbonate/Cit Ac	13	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Etodolac	Etodolac	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Otezla	Apremilast	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	11
Tramadol Hcl Er	Tramadol Hcl	13	suppressed
Valsartan	Valsartan	13	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	12	suppressed
Baclofen	Baclofen	12	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Bumetanide	Bumetanide	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error